Showing results (771-780 of 5,983) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|March 16, 2005
Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradationYasusei Kudo, Shojiro Kitajima, Ikuko Ogawa, et al.Molecular Cancer Therapeutics|October 17, 2007
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activityChentao Lin, Wei Wei, Jinchun Zhang, et al.Molecular Cancer Therapeutics|October 17, 2007
Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activityEun-Ryeong Hahm, Shivendra V SinghMolecular Cancer Therapeutics|October 17, 2007
p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cellsSrirupa Roy, Manjinder Kaur, Chapla Agarwal, et al.Molecular Cancer Therapeutics|October 17, 2007
Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemidShanghua Yin, Fernando Cabral, Sudha VeeraraghavanMolecular Cancer Therapeutics|August 19, 2007
Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species mediated damageSe-Yeong Oh, Young-Woo Sohn, Jong-Whi Park, et al.Molecular Cancer Therapeutics|August 19, 2007
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical modelsBarry R Davies, Armelle Logie, Jennifer S McKay, et al.Molecular Cancer Therapeutics|August 19, 2007
Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genisteinAngela Ping Ping Ng, Dawn Sijin Nin, Jek Howe Fong, et al.Molecular Cancer Therapeutics|August 19, 2007
A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2Ann S J Yeoh, Rachel J Gibson, Eric E K Yeoh, et al.Molecular Cancer Therapeutics|August 3, 2007
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivoQun-sheng Ji, Mark J Mulvihill, Maryland Rosenfeld-Franklin, et al.Pageof 599